SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-20-010887
Filing Date
2020-03-16
Accepted
2020-03-13 18:00:37
Documents
6
Period of Report
2020-05-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A nvus-pre14a_20200512.htm PRE 14A 996683
2 GRAPHIC gcs3q2abrj0e000005.jpg GRAPHIC 74514
3 GRAPHIC gcs3q2abrj0e000002.jpg GRAPHIC 2177
4 GRAPHIC gcs3q2abrj0e000004.jpg GRAPHIC 89048
5 GRAPHIC gcs3q2abrj0e000001.jpg GRAPHIC 4022
6 GRAPHIC gcs3q2abrj0e000003.jpg GRAPHIC 4022
  Complete submission text file 0001564590-20-010887.txt   1237910
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36620 | Film No.: 20714393
SIC: 2834 Pharmaceutical Preparations